Form D · Other Technology
Maverix Biomics, Inc.
San Mateo, CA · CIK 0001595711
Offering snapshot reported Jan 3, 2014 · SEC filing
- Reported sold
- $7.99M Offering amount: $8.61M
- Investors reported
- 42 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 18, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 3, 2014 | Initial | $7,993,889 | No comparison | 42 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-209197
Source: Form D, filed Jan 3, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Patricia Pak Lee Chan | Executive |
| Todd Michael Johnson Lowe | Director, Executive, Promoter |
| David Mandelkern | Director, Executive, Promoter |
| Paul Pickering | Executive |
| Gordon Ringold | Director, Promoter |
Issuer details
Industry: Other Technology (See others in industry)
Address:
1670 South Amphlett Boulevard Suite 214
San Mateo, CA, 94402
San Mateo, CA, 94402